JACC
HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
QUICK SEARCH:   [advanced]


     

J Am Coll Cardiol, 2006; 47:1530-1537, doi:10.1016/j.jacc.2005.11.066 (Published online 23 March 2006).
© 2006 by the American College of Cardiology Foundation
This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (25)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Valgimigli, M.
Right arrow Articles by Serruys, P. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Valgimigli, M.
Right arrow Articles by Serruys, P. W.

Distal Left Main Coronary Disease Is a Major Predictor of Outcome in Patients Undergoing Percutaneous Intervention in the Drug-Eluting Stent Era

An Integrated Clinical and Angiographic Analysis Based on the Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital (RESEARCH) and Taxus-Stent Evaluated At Rotterdam Cardiology Hospital (T-SEARCH) Registries

Marco Valgimigli, MD, Patrizia Malagutti, MD, Gaston A. Rodriguez-Granillo, MD, Héctor M. Garcia-Garcia, MD, Jawed Polad, MBChB, MRCP, Keiichi Tsuchida, MD, PhD, Evelyn Regar, MD, PhD, Willem J. Van der Giessen, MD, PhD, Peter de Jaegere, MD, PhD, Pim De Feyter, MD, PhD and Patrick W. Serruys, MD, PhD*

Erasmus Medical Center, Thoraxcenter, Rotterdam, the Netherlands.


Figure 1
View larger version (20K):

[in a new window]
  		Figure 1 Adverse events in patients treated for distal left main coronary artery (LMCA) disease (DLMD) as compared with patients treated for nondistal LMCA disease (NDLMD). Cumulative risk of major adverse cardiac events (MACE) (A) and target vessel revascularization (TVR) (B) in the whole population, and cumulative risk of MACE (C) and TVR (D) in the elective population.

 

Figure 2
View larger version (11K):

[in a new window]
  		Figure 2 Cumulative risk of major adverse events in patients with high surgical risk (Parsonnet score >15) as compared with that of patients at low surgical risk (Parsonnet score <15) (A), and in patients at high surgical risk affected by DLMD as compared with that of patients at high surgical risk and NDLMD, low surgical risk and DLMD, and low surgical risk and NDLMD (B). *p = 0.002; {dagger}p = 0.048; {ddagger}p = 0.066. Abbreviations as in Figure 1.

 




HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
Copyright © 2006 by the American College of Cardiology Foundation.